The generative AI in healthcare and life sciences market map
From clinical operations to drug development, we mapped 85+ startups bringing generative AI to the healthcare and life sciences industries.
From clinical operations to drug development, we mapped 85+ startups bringing generative AI to the healthcare and life sciences industries.
From AI’s ascendance to cautious dealmaking, we break down the trends reshaping digital health in 2024 using CB Insights data.
From in-home humanoids to autonomous labs, we highlight the growing opportunities in robotics markets for providers and other healthcare stakeholders.
We mined Mayo Clinic’s investments to determine how AI is shaping the next generation of healthcare.
While global funding falls, M&A activity picks up in digital health.
We analyzed Eli Lilly’s tech-focused acquisitions, investments, and partnerships to discern the company’s strategic priorities.
Healthcare incumbents, big tech, and startups alike are using AI to address key pain points in clinical workflows. We break down the fast-growing market for ambient AI solutions in healthcare.
This report uses the CB Insights TECH Framework to rank clinical trials markets based on current commercial readiness and momentum.
Bet on the right digital health markets. Dig into your rivals’ health tech strategies. Identify the best digital health startups.
From medical scribes to clinical trial platforms, AI-driven solutions are key targets of digital health M&A deals in 2024 so far. Here’s where we’re seeing the most activity.
Funding in digital health drops, but larger check sizes and an uptick in exits highlight bright spots for the industry in Q2’24.
Assess how prepared US health systems are to adopt and respond to rapidly evolving AI technologies.
Tech leaders are aggressively applying cloud computing and generative AI to tackle issues in healthcare. We look at how 4 tech giants are building their positions in the industry using strategic investments, partnerships, and product launches.
This report uses the CB Insights TECH Framework to rank femtech markets based on current commercial readiness and momentum.
We mined Google’s investments and partnerships to discern the company's strategic priorities in healthcare.
While digital health funding rebounds in Q1'24, deal count hits a multi-year low.
We mined Microsoft's acquisitions, investments, and partnerships to discern the company's strategic priorities in healthcare.
We analyzed early-stage investment trends to uncover which digital health markets — from tele-psychiatry to virtual & hybrid women's healthcare — are quickly evolving and how these will impact the space.
In 2023, digital health funding and deals continue to plummet from pandemic highs.
From protein design to synthetic patient data, we break down the categories of tech vendors bringing generative AI into the research and clinical settings.
We mined Nvidia's investments and partnerships to discern the company’s strategic priorities in healthcare.
From claims management to automated coding, we break down the categories of vendors helping healthcare providers maximize revenue and minimize costs.
From EHR-based patient recruitment to decentralized clinical trials, we break down the critical categories of vendors digitizing clinical trials.
We mined Mayo Clinic’s investments and partnerships to discern the company's strategic priorities.
We mined Amazon’s acquisitions, investments, and partnerships to discern the company’s strategic priorities in healthcare.
We mined Cigna’s acquisitions, investments, and partnerships to discern the company's strategic priorities.